These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1970208)

  • 1. [Therapy study of chronic polyarthritis with sulfasalazine with special emphasis on the profile of side effects].
    Lonauer G
    Z Rheumatol; 1990; 49(1):44-9. PubMed ID: 1970208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic maintenance and tolerance of sulfasalazine in rheumatoid polyarthritis. Retrospective study of 95 patients].
    Pertuiset E; Lioté F; Chevret S; Bardin T; Dryll A; Kuntz D
    Rev Rhum Mal Osteoartic; 1992 Oct; 59(9):545-52. PubMed ID: 1363000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the blood picture in sulfasalazine therapy of rheumatoid arthritis].
    Rave O
    Z Rheumatol; 1987; 46(2):86-91. PubMed ID: 2885991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sulfasalazine (Azulfidine RA) versus aurothioglucose in therapy of chronic polyarthritis--status report of an open, comparative, multicenter long-term study].
    Schattenkirchner M
    Z Rheumatol; 1987; 46(2):67-70. PubMed ID: 2885986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic therapy of rheumatoid arthritis. Comparison of methotrexate and sulfasalazine].
    Keitel W; Keitel R; Pap T
    Z Gesamte Inn Med; 1993 Oct; 48(10):480-3. PubMed ID: 7903012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5-year followup.
    Jones E; Jones JV; Woodbury JF
    J Rheumatol; 1991 Feb; 18(2):195-8. PubMed ID: 1673722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A one-year, open, prospective study of sulfasalazine in the treatment of rheumatoid arthritis: adverse reactions and clinical response in relation to laboratory variables, drug and metabolite serum levels, and acetylator status.
    Chalmers IM; Sitar DS; Hunter T
    J Rheumatol; 1990 Jun; 17(6):764-70. PubMed ID: 1974926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of responses to and adverse effects of graded doses of sulfasalazine in the treatment of rheumatoid arthritis.
    Skosey JL
    J Rheumatol Suppl; 1988 Sep; 16():5-8. PubMed ID: 2903927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methotrexate and salazosulfapyridine in the long-term treatment of rheumatoid arthritis].
    Ichikawa Y; Shinozawa T; Yoshida T; Kameda H; Suzuki Y; Kawai S; Yamada H; Matsuda T
    Ryumachi; 1995 Aug; 35(4):663-70. PubMed ID: 7482063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine induced lupus in rheumatoid arthritis.
    Caulier M; Dromer C; Andrieu V; Le Guennec P; Fournie B
    J Rheumatol; 1994 Apr; 21(4):750-1. PubMed ID: 7913504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
    J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine in the treatment of rheumatoid arthritis.
    Pelísková Z; Vácha J; Trnavský K
    Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmachem's salazopyrine in rheumatoid arthritis].
    Konstantinova M; Konstantinova V
    Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sulfasalazine for the treatment of rheumatoid polyarthritis. Results after 36 months].
    Ghozlan R; Dupuis M; Guillon C; Jorro P; Lecarpentier C; Schwak A
    Rev Rhum Mal Osteoartic; 1990; 57(7-8):585-7. PubMed ID: 1980752
    [No Abstract]   [Full Text] [Related]  

  • 19. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
    Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.